CAWM
BSX icon

Capital A Wealth Management’s Boston Scientific BSX Stock Holding History

Capital A Wealth Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-124
Closed -$12.5K – 479
2025
Q1 		$12.5K Hold
124
– – 0.01% 275
2024
Q4 		$11.1K Buy
+124
New +$10.9K 0.02% 298

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital A Wealth Management's BSX Position: Q2 2025 in Review

Capital A Wealth Management sold out of Boston Scientific (BSX) in Q2 2025, closing a stake of 124 shares — an estimated $12.5K sold.

Capital A Wealth Management first reported a position in BSX in Q4 2024 and held it in 2 quarters. The position peaked at $12.5K in Q1 2025. 1,688 funds tracked by Wall St. Rank hold BSX as of Q2 2025.

  • Capital A Wealth Management reported no remaining Boston Scientific position as of Q2 2025 after selling out during the quarter.
  • Capital A Wealth Management sold 124 Boston Scientific shares in Q2 2025, an estimated $12.5K.
  • Capital A Wealth Management first reported a position in Boston Scientific in Q4 2024 and held it in 2 quarters.
  • Capital A Wealth Management's Boston Scientific position peaked at $12.5K in Q1 2025.
  • 1,688 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2025.

Based on Capital A Wealth Management's 13F filing for Q2 2025, filed 26 Sep 2025.